Quotes Newron Pharmaceuticals S.p.A. OTC Markets

Stocks

NWPHF

IT0004147952

Biotechnology & Medical Research

Market Closed - 09:32:58 2026-03-31 EDT 5-day change 1st Jan Change
20.00 USD +113.68% Intraday chart for Newron Pharmaceuticals S.p.A. -.--% +113.68%

Stock exchange

Performance

1 day+113.68%
Current year+113.68%
1 year+113.68%
3 years+221.54%
5 years+614.29%
10 years-3.61%

Volumes

markets
Daily volume
101
Estimated daily volume
101
Record volume 1
30,000
Record volume 2
20,092
Record volume 3
20,000
Capital turnover ratio
0
Float rotation
0

Basic data

Market Cap (USD)
209,161,749
Net sales (EUR)
19,126,000
Net sales (USD)
21,533,438
Number of employees
27
Sales / Employee (EUR)
708,370
Sales / Employee (USD)
797,535
Free-Float
87.16%
Free-Float capitalization (USD)
182,308,478

Indicators

Moving average 20 days
1
Moving average 50 days
0.4
Moving average 100 days
20
Price spread / (MMA20)
-95.00%
Price spread / (MMA50)
-98.00%
Price spread / (MMA100)
-.--%
RSI 9 days
47.06
RSI 14 days
48.15

Change 5-day change 1-year change 3-year change Capi.($)
+113.68%-.--%+113.68%+221.54% 209M
+4.16%+3.04%+49.37%+94.17% 74.41B
-1.09%-1.51%+24.46%+78.24% 59.26B
+1.09%-1.05%+3.83%+33.94% 47.14B
-3.02%-5.20%+27.94%+32.51% 42.91B
+0.31%+3.02%+348.95%+643.82% 44.13B
-1.96%-0.33%+7.04%+99.46% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.77%+2.83%+29.52%+22.61% 29.31B
-4.86%-10.66%-26.27%+330.06% 23.71B
Average +10.89%-0.52%+58.86%+160.76% 39.27B
Weighted average by Cap. +0.08%-0.32%+57.98%+145.73%

Historical Quotes: Newron Pharmaceuticals S.p.A.

DateOpeningHighLowCloseVolumeChange
Chart Newron Pharmaceuticals S.p.A.

Price Extremes

Current year 20
Extreme 20
20
1 year 20
Extreme 20
20
3 years 5.22
Extreme 5.22
20
5 years 2.1
Extreme 2.1
20
10 years 1.8
Extreme 1.801
27.5

Monthly variations

Annual variations

2026+113.68%
2024+79.31%
2023+148.57%
2021-13.96%
2020-67.46%
2019-31.82%
2018-4.35%
2017-44.58%
2016+245.83%
2011+5.99%
2010-75.60%
2009-5.31%
  1. Stock Market
  2. Stocks
  3. NWRN Stock
  4. NWPHF Stock
  5. Quotes Newron Pharmaceuticals S.p.A.